Method for treating type II diabetes mellitus
AssigneeHoffman-La Roche Inc.
InventorJonathan Brian Hauptman
Life of this patent
Estimating the term…
Abstract
A method for treating or preventing type II diabetes mellitus comprising administering an effective amount of a gastrointestinal lipase inhibitor, such as, tetrahydrolipstatin.
Claims12
A method of treating type II diabetes mellitus by reducing hemoglobin A1c levels, which comprises orally administering to a human subject afflicted with type II diabetes mellitus an amount of a pharmaceutical preparation in unit dosage form, which consists essentially of tetrahydrolipstatin formulated as an oral composition, the amount of tetrahydrolipstatin being effective to reduce hemoglobin A1c levels and in the range of from about 60 to 720 mg of tetrahydrolipstatin per day.
Dependencies are inferred from the claim text.